Coronavirus Information for the UC San Diego Community

Our leaders are working closely with federal and state officials to ensure your ongoing safety at the university. Stay up to date with the latest developments. Learn more.

A systematic review of recently reported marine derived natural product kinase inhibitors

TitleA systematic review of recently reported marine derived natural product kinase inhibitors
Publication TypeJournal Article
Year of Publication2019
AuthorsLi T., Wang N., Zhang T., Zhang B., Sajeevan T.P, Joseph V., Armstrong L., He S., Yan X.J, Naman C.B
Volume17
Date Published2019/09
Type of ArticleReview
Accession NumberWOS:000487959700019
Keywordsa-c; alkaloids; breast-cancer cells; bromopyrrole; drug development; in-vitro; kinase inhibitors; marine natural products; nf-kappa-b; Pharmacology & Pharmacy; ray crystal-structure; sea; Sponge; tlr4-myd88-mediated inhibition; tumor-growth
Abstract

Protein kinases are validated drug targets for a number of therapeutic areas, as kinase deregulation is known to play an essential role in many disease states. Many investigated protein kinase inhibitors are natural product small molecules or their derivatives. Many marine-derived natural products from various marine sources, such as bacteria and cyanobacteria, fungi, animals, algae, soft corals, sponges, etc. have been found to have potent kinase inhibitory activity, or desirable pharmacophores for further development. This review covers the new compounds reported from the beginning of 2014 through the middle of 2019 as having been isolated from marine organisms and having potential therapeutic applications due to kinase inhibitory and associated bioactivities. Moreover, some existing clinical drugs based on marine-derived natural product scaffolds are also discussed.

DOI10.3390/md17090493
Student Publication: 
No
Research Topics: